Effects of 17β-oestradiol on cerebral ischaemic damage and lipid peroxidation

Introduction: Numerous studies demonstrate oestrogen's neuroprotective effect in stroke models, although the mechanisms are unclear. Since oestrogen is an antioxidant, we tested the hypothesis that oestrogen reduces stroke-induced damage by reducing free radical damage, particularly lipid peroxidation. Methods: Sprague-Dawley rats were ovariectomised and a 17 beta-oestradiol (0.25 mg, 21 day release) or placebo pellet implanted subcutaneously. Two weeks later, permanent middle cerebral artery occlusion (MCAO) was induced by intraluminal filament. At 2 and 24 h post-MCAO, neurological deficits were assessed. At the 24 h end point, plasma oestradiol was measured and brain sections stained with haematoxylin and eosin or lipid peroxidation marker, 4-hydroxynonenol (4-HNE) immurrohistochernistry carried out to measure infarct volume and volume of tissue displaying oxidative damage, respectively. Results: Plasma 17 beta-oestradiol in oestradiol and placebo groups was 72.6 +/- 38.0 and 9.3 +/- 7.4 pg/ml (mean +/- SD), respectively. Infarct volume was significantly increased (118%) with oestradiol treatment (oestradiol = 124 +/- 84.5, placebo = 57 +/- 46.4 mm(3), mean SD, P < 0.05). The relationship between 4-HNE and infarct volume was significantly influenced by 17 beta-oestradiol. Neurological deficits were similar between groups (oestradiol median = 13, placebo = 14, max score = 33). Conclusion: Two week pre-treatment with a high physiological dose of 17 beta-oestradiol increased infarct volume after permanent MCAO. Although contrary to our original hypothesis, this result demonstrates that oestrogen does have the capacity to promote detrimental actions in the stroke-injured brain. Given the wide use of oestrogen (contraception, osteoporosis and menopause), more research to clarify the influence of oestrogen on brain injury is urgently required. (c) 2005 Elsevier B.V. All rights reserved.